These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 23908467)
1. How T cells trigger the dissociation of the endothelial receptor phosphatase VE-PTP from VE-cadherin. Vockel M; Vestweber D Blood; 2013 Oct; 122(14):2512-22. PubMed ID: 23908467 [TBL] [Abstract][Full Text] [Related]
2. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. Broermann A; Winderlich M; Block H; Frye M; Rossaint J; Zarbock A; Cagna G; Linnepe R; Schulte D; Nottebaum AF; Vestweber D J Exp Med; 2011 Nov; 208(12):2393-401. PubMed ID: 22025303 [TBL] [Abstract][Full Text] [Related]
3. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. Nottebaum AF; Cagna G; Winderlich M; Gamp AC; Linnepe R; Polaschegg C; Filippova K; Lyck R; Engelhardt B; Kamenyeva O; Bixel MG; Butz S; Vestweber D J Exp Med; 2008 Nov; 205(12):2929-45. PubMed ID: 19015309 [TBL] [Abstract][Full Text] [Related]
4. Leukocytes talking to VE-cadherin. Ley K Blood; 2013 Oct; 122(14):2300-1. PubMed ID: 24092927 [TBL] [Abstract][Full Text] [Related]
5. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin. Frye M; Dierkes M; Küppers V; Vockel M; Tomm J; Zeuschner D; Rossaint J; Zarbock A; Koh GY; Peters K; Nottebaum AF; Vestweber D J Exp Med; 2015 Dec; 212(13):2267-87. PubMed ID: 26642851 [TBL] [Abstract][Full Text] [Related]
6. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca Soni D; Regmi SC; Wang DM; DebRoy A; Zhao YY; Vogel SM; Malik AB; Tiruppathi C Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L1003-L1017. PubMed ID: 28385807 [TBL] [Abstract][Full Text] [Related]
7. Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation. Huo Z; Kong Y; Meng M; Cao Z; Zhou Q Vascul Pharmacol; 2019 Jun; 117():7-14. PubMed ID: 29894844 [TBL] [Abstract][Full Text] [Related]
8. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. Nawroth R; Poell G; Ranft A; Kloep S; Samulowitz U; Fachinger G; Golding M; Shima DT; Deutsch U; Vestweber D EMBO J; 2002 Sep; 21(18):4885-95. PubMed ID: 12234928 [TBL] [Abstract][Full Text] [Related]
9. Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction. Yan M; Zhang X; Chen A; Gu W; Liu J; Ren X; Zhang J; Wu X; Place AT; Minshall RD; Liu G FASEB J; 2017 Nov; 31(11):4759-4769. PubMed ID: 28701303 [TBL] [Abstract][Full Text] [Related]
10. VE-PTP stabilizes VE-cadherin junctions and the endothelial barrier via a phosphatase-independent mechanism. Juettner VV; Kruse K; Dan A; Vu VH; Khan Y; Le J; Leckband D; Komarova Y; Malik AB J Cell Biol; 2019 May; 218(5):1725-1742. PubMed ID: 30948425 [TBL] [Abstract][Full Text] [Related]
12. Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2. Drexler HCA; Vockel M; Polaschegg C; Frye M; Peters K; Vestweber D Mol Cell Proteomics; 2019 Oct; 18(10):2058-2077. PubMed ID: 31427368 [TBL] [Abstract][Full Text] [Related]
13. HIF2α signaling inhibits adherens junctional disruption in acute lung injury. Gong H; Rehman J; Tang H; Wary K; Mittal M; Chaturvedi P; Zhao YY; Komarova YA; Vogel SM; Malik AB J Clin Invest; 2015 Feb; 125(2):652-64. PubMed ID: 25574837 [TBL] [Abstract][Full Text] [Related]
14. Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin. Dorofejeva O; Barr AJ PLoS One; 2017; 12(9):e0184574. PubMed ID: 28926625 [TBL] [Abstract][Full Text] [Related]
15. Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation. van Buul JD; Anthony EC; Fernandez-Borja M; Burridge K; Hordijk PL J Biol Chem; 2005 Jun; 280(22):21129-36. PubMed ID: 15778498 [TBL] [Abstract][Full Text] [Related]
16. Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Wessel F; Winderlich M; Holm M; Frye M; Rivera-Galdos R; Vockel M; Linnepe R; Ipe U; Stadtmann A; Zarbock A; Nottebaum AF; Vestweber D Nat Immunol; 2014 Mar; 15(3):223-30. PubMed ID: 24487320 [TBL] [Abstract][Full Text] [Related]
17. VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes. Siragusa M; Oliveira Justo AF; Malacarne PF; Strano A; Buch A; Withers B; Peters KG; Fleming I Cardiovasc Res; 2021 May; 117(6):1546-1556. PubMed ID: 32653904 [TBL] [Abstract][Full Text] [Related]
18. Plakoglobin maintains the integrity of vascular endothelial cell junctions and regulates VEGF-induced phosphorylation of VE-cadherin. Muramatsu F; Kidoya H; Naito H; Hayashi Y; Iba T; Takakura N J Biochem; 2017 Jul; 162(1):55-62. PubMed ID: 28158602 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 Tat C phosphorylates VE-cadherin complex and increases human brain microvascular endothelial cell permeability. Mishra R; Singh SK BMC Neurosci; 2014 Jun; 15():80. PubMed ID: 24965120 [TBL] [Abstract][Full Text] [Related]
20. PECAM-1 supports leukocyte diapedesis by tension-dependent dephosphorylation of VE-cadherin. Arif N; Zinnhardt M; Nyamay'Antu A; Teber D; Brückner R; Schaefer K; Li YT; Trappmann B; Grashoff C; Vestweber D EMBO J; 2021 May; 40(9):e106113. PubMed ID: 33604918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]